Debt to Equity Ratio Chart

View Debt to Equity Ratio for CERS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 1.097
March 31, 2026 1.441
December 31, 2025 1.510
September 30, 2025 1.598
June 30, 2025 1.784
March 31, 2025 1.792
December 31, 2024 1.747
September 30, 2024 1.830
June 30, 2024 1.993
March 31, 2024 2.038
December 31, 2023 1.823
September 30, 2023 1.971
June 30, 2023 1.732
March 31, 2023 1.534
December 31, 2022 1.290
September 30, 2022 1.196
June 30, 2022 1.161
March 31, 2022 1.115
December 31, 2021 1.035
September 30, 2021 1.028
June 30, 2021 0.9716
March 31, 2021 0.8932
December 31, 2020 0.6444
September 30, 2020 0.5827
June 30, 2020 0.5576
Date Value
March 31, 2020 0.5696
December 31, 2019 1.130
September 30, 2019 1.059
June 30, 2019 0.979
March 31, 2019 0.8677
December 31, 2018 0.3534
September 30, 2018 0.3252
June 30, 2018 0.3299
March 31, 2018 0.3483
December 31, 2017 0.7652
September 30, 2017 0.8009
June 30, 2017 0.4444
March 31, 2017 0.4377
December 31, 2016 0.3353
September 30, 2016 0.2676
June 30, 2016 0.266
March 31, 2016 0.2374
December 31, 2015 0.209
September 30, 2015 0.2079
June 30, 2015 0.18
March 31, 2015 0.0899
December 31, 2014 0.2378
September 30, 2014 0.2086
June 30, 2014 0.2228
March 31, 2014 0.0728

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
DexCom, Inc. 0.5335
Abbott Laboratories 0.638
AngioDynamics, Inc. 0.0641
Alphatec Holdings, Inc. 52.37
AtriCure, Inc. 0.1437